DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 Adial’s Micro-formulation: Opening New Massive Alcohol Use Disorder Treatment Market Opportunities Visit Post
2 Navigating the Most Use Cases of Robotic Process Automation (RPA) in Healthcare Visit Post
3 Digital Twin Technology - Assessing the Growing Role and Its Evolving Applications in Healthcare Market Visit Post
4 Understanding How Emerging Applications of Nanotechnology are Upgrading the Healthcare Delivery? Visit Post
5 Interoperability Solutions in Healthcare - Evolving Market Dynamics and Improving Health Outcomes Visit Post
6 What Impact Does Speech and Voice Recognition Technology Bring to the Healthcare System? Visit Post
7 Strategic Importance of Portfolio Management in the Pharma and Healthcare Industry Visit Post
8 How Cloud Computing is Transforming the Healthcare Industry Dynamics? Visit Post
9 Interpreting the Growth and Major Developments in the Medical Device Contract Manufacturing Market Visit Post
10 Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase the Odds of Success? Visit Post
11 How Blockchain is Transforming the Healthcare Industry? Visit Post
12 How Medication Management Apps are Adding Value to the Treatment Journey? Visit Post
13 Wearable Technology in Healthcare: Major Benefits and Trends Visit Post
14 The Future Of Medicinal Care - Medical Robots Visit Post
15 How Technology is Providing a New Dimension to the Clinical Trials? Visit Post
16 Robotic Surgery: Navigating the Growing Demand, Ongoing Trends & Developments in the Global Market Visit Post
17 22 Healthcare Trends & Innovations to Watch in 2022 and Beyond Visit Post
18 Cybersecurity in Healthcare: Major Threats and Challenges Visit Post
19 Contract Organizations Impacting Pharma Development and Manufacturing Visit Post
20 Evaluating the Essential Factors Building the Value-Based Healthcare Model Visit Post
21 Competitive Intelligence: Stay Ahead of the Competitors in 2022! Visit Post
22 Smart Hospital: How it is Shaping the Future of Healthcare Delivery Visit Post
23 Which Countries Top the Chart in Global Pharmaceutical Market? Visit Post
24 Healthcare Data Breach: What it Means for Companies and the Consumer? Visit Post
25 How Healthcare Apps are Adding New Perspectives to the Healthcare Industry? Visit Post
26 Reliable Experts in Pharmacology Market: Pharma Consultants Visit Post
27 Business Consultants: An Intense Drive to Work Excellence Visit Post
28 Analyzing the Prospects of Drones in Healthcare Delivery System Visit Post
29 Top 7 Pharma Industry Leaders in 2020 By the Numbers Visit Post
30 FDA approval to Keytruda and Lenvima; FibroGen's Roxadustat; Pfizer’s TICOVAC; Ipsen’s Palovarotene; Jazz Pharma’s Xywav; Seagen-RemeGen’s Cancer Medicine Visit Post
31 Reimagining Clinical Trials: Why are Virtual Clinical Trials Becoming the New Normal? Visit Post
32 Technological Innovation: The Medicine of Healthcare Visit Post
33 MedTech Wrap Up Visit Post
34 Wearable Devices: Weighing the Potential Benefits and Pitfalls of the Innovative Wearable Products Visit Post
35 Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collaborate; Kozin bags $60M Visit Post
36 What factors are guiding the Growth of Endoscopy Fluid Management Systems in the MedTech Market? Visit Post
37 Latest Medtech Commercial, Regulatory and Clinical Updates For - Abbott, BD, CooperVision, Procyrion, TricValve, and others Visit Post
38 Which Companies are Vying to get a Major Chunk in the Elastomeric Pump Market? Visit Post
39 MedTech Industry: Commercial, Regulatory and Clinical Updates Visit Post
40 The Rising Burden of Substance Use Disorder And The Treatment Scenario Visit Post
41 MedTech Industry Roars Back as FDA Approvals Soar Visit Post
42 E-Pharmacies: A Disruptive Innovation and the Future of Pharma Sector Visit Post
43 Merck, Gilead teams up for HIV treatment; Bright Future for Sanofi/Regeneron’s Libtayo; Roche acquires GenMark; FDA okays Melinta's Kimyrsa Visit Post
44 Diagnosing At-Home: Are At-Home Diagnostic Tools The New Trends? Visit Post
45 Bluebird suspends gene therapy trials; Cortexyme tripped up by FDA hold; Guardant Health launches surveillance blood test; Enhertu scores approval Visit Post
46 Healthcare in 2021: Top Disruptions Bound To Impact The Way Healthcare Is Delivered Visit Post
47 Merck, Eisai in renal cancer market; G1 Therapeutics on Cosela’s approval; Takeda's Maribavir; Astellas/Seagen Padcev Visit Post
48 Pfizer/ OPKO Health’s Somatrogon; FDA EU for SCONE device; Antengene ATG-010 for rrMM and rrDLBCL; SanBio STEMTRA Phase 2 Interim Results Visit Post
49 Alcohol Use Disorder (AUD): When Drinking Becomes A Headache Visit Post
50 Treating Patients with Software: Digital Therapeutics Visit Post
51 Will Wearable Devices be Streamlined in Healthcare? Visit Post
52 Creating Future of MedTech Industry with Artificial Intelligence Visit Post
53 Bioterrorism: A Threat To The Healthcare And Global Peace Visit Post
54 Trump vs. Biden: What is in Store for Healthcare Domain? Visit Post
55 How Will Artificial Intelligence Change The Future Of Healthcare? Visit Post
56 Adding Value to the Health with a Value-Based Healthcare Model Visit Post
57 The State of Alternative Medicine In The Healthcare Visit Post
58 Healthcare Delivery System: What lies in the future? Visit Post
59 EicOsis receives USD 15M to fuel its non-opioid pain therapy; Alexion Pharmaceuticals buys Achillion Pharmaceuticals; Ipsen adds another drug to its rare disease pipeline Visit Post
60 ImaginAb joins hands with AstraZeneca, Pfizer, Takeda Visit Post
61 Sanifit nets USD 80.9 M; FDA approves Dupixent for CRS; AbbVie buys Allergan Visit Post
62 Notizia Visit Post
63 Complex regional pain syndrome (CRPS)-A debilitating disease Visit Post
64 The Business Cocktail Visit Post
65 Approach for Cystic Fibrosis; An alternative for Statins; Oral medications not safe; Carbon monoxide poisoning treatment gets approval Visit Post
66 BioNTech lines up $800M; Deerfield remunerates; Britain's Smith & Nephew to acquire Osiris Visit Post
67 Welcome the Slumber Visit Post
68 NO SMOKING DAY Visit Post
69 Wearing Technology to stay fit Visit Post
70 ColdZyme inactivates viruses; Med for rare genetic disease; Common oral bacteria accelerate Colon cancer; CEPI and CureVac to develop an mRNA vaccine; Celastrol’s effectiveness Visit Post
71 Biodesix collaborates with MRM; Avoiding flu with an antibody; Soliris clears trial Visit Post
72 Juvenescence raises $46M; Brainsway files for IPO; Life Biosciences raises Visit Post
73 Apollomics raises; Pear Therapeutics raises $64M; Lilly to acquire Loxo Visit Post
74 Vedanta raises; Relay Therapeutics reels in; Gene therapy for SMA Visit Post
75 Prometic bags $50M; Vedanta receives $12M; Humira biosimilar deal Visit Post
76 Newsletter Visit Post
77 Notizia Visit Post
78 Cholera vaccine delivered; Rice-inspired breakthroughs; International partnerships Visit Post
79 Notizia Visit Post
80 Epic Sciences garners; Tvardi gets financing; Galera raises; Fund for cancer research Visit Post
81 Business Cocktail Visit Post
82 Immune Checkpoint Activators (ICA): Dynamic Therapeutic Targets Visit Post
83 Business Cocktail Visit Post
84 In vivo monitoring of T cell–dendritic cell interactions by intercellular enzymatic labelling Visit Post
85 Adapsyn signed; Evolus filed; BioNTech signed a deal; Nordisk’s deal Visit Post
86 Business Cocktail Visit Post
87 December 7 Business Cocktail Visit Post
88 Toll-Like Receptor Modulators: Emerging therapy for many indications Visit Post
89 Ketamine to work in mice Visit Post
90 EMA to relocate to Amsterdam; Roche’s prospects; Amgen’s Humira Biosimilar delayed; Purdue’s opioid lawsuit Visit Post
91 Chemists may help solve the air-pollution health crisis Visit Post
92 CAR-T Phase I trials; ContraVir Announces; Merck acquired; Excision BioTherapeutics bags $10M Visit Post
93 Novartis on AMD drug; Hospira recall of vials; Takeda wraps up; FDA bans imports Visit Post
94 Bio-manufacturing with Spider Silk for pre-term babies Visit Post
95 Chemotherapy-Induced Nausea and Vomiting Side effects Visit Post
96 Acromegaly and Gigantism: It’s all about excessive Growth Hormone… Visit Post
97 Valeant's asset-sale; Sanofi coughs up $19.8M; Sanofi's Genzyme; India's Alkem; GSK’s inhalers Visit Post
98 Medical tourism in India Visit Post
99 BioAsia 2017 Visit Post
100 Payers block EpiPen; Allergan charged; AbbVie's Humira; Baxter paying $18M Visit Post
101 Biosimilars: A benchmark in Pharmaceutical Business Visit Post
102 Aurobindo takes top generic spot; Valeant unloads Dendreon; Ipsen strikes $1B deal; Takeda shells out $5.2B Visit Post
103 Sanofi, Regeneron one step closer; Pharma's deal; J&J and Actelion deal Visit Post
104 Novartis Buys; FDA approves; Mayne Pharma Launches; Oxford Genetics Receives Grant Visit Post
105 Fresenius Kabi introduced Bivalirudin; Envigo Launches; Mylan's MAA accepted; Pricing hit pharma Visit Post
106 Merck launches Biosimilars, ABITEC announces extension, First human clinical trial, FDA awards 2grants, Corden Pharma Expands, Juniper Pharma Services Offers Visit Post
107 JAK Inhibitors: New Lifeline for Hair Loss Treatment Visit Post
108 Bayer AG & Evotec AG’s deal; Plasticell and CellSpring AG’s deal; Allergan Acquires Akarna; Cambrex Acquires Pharmacore Visit Post
109 Sygnis AG and ECACC Collaboration; BioNTech and Genentech Partnership; Partnership between Zydus Cadila and Takeda; Global Agreement between Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Visit Post
110 NATCO Pharma surges; AstraZeneca falls; US patent office rules Visit Post
111 Lupin acquired; FDA grants approval; NATCO gets approval; Wockhardt Ltd. gets import alert; Patent fight Visit Post